ArticleCancer immunology, immunotherapy : CII2023

BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia.

Christian Sordo-Bahamonde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.